A Study of YL-17231 in Patients With Advanced Solid Tumors (clinicaltrials.gov) - Oct 12, 2023 - P1 | N=80 | Recruiting | Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
Metastases • New P1 trial • Colorectal Cancer • Gastrointestinal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • KRAS • MSI • PD-L1
|